Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266.

作者: Klara Gadó , Éva Pállinger , Péter Kovács , Edit Takács , István Szilvási

DOI: 10.1016/S0165-2478(02)00008-1

关键词:

摘要: In certain types of solid tumours and lymphomas prolactin (PRL) potentiates tumour cell proliferation exerts anti-apoptotic effect. Tumour cells themselves can produce PRL express PRL-receptors. Hyperprolactinemia is associated with different tumours, also. Multiple myeloma (MM) a haematological malignancy caused by the clonal expansion terminally differentiated plasma in bone marrow. Recently, we demonstrated immunostaining marrow MM patients an elevated level serum advanced disease. present study, tested effect on U266 human line constitutive melphalan-stimulated intracytoplasmic cells. Exogeneous inhibited immunoglobulin (Ig) production Concerning etoposide-induced apoptosis, had double-faceted depending applied dose: high, pharmacological doses (corresponding to hyperprolactinemia), whereas near physiological exerted pro-apoptotic These data indicate definite line. We direct inhibition growth, while its reciprocal apoptosis refers important regulatory role PRL.

参考文章(31)
J. Pontén, K. Nilsson, S. G. O. Johansson, H. Bennich, Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clinical and Experimental Immunology. ,vol. 7, pp. 477- 489 ,(1970)
Nie-Lin Ge, Stuart Rudikoff, Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood. ,vol. 96, pp. 2856- 2861 ,(2000) , 10.1182/BLOOD.V96.8.2856
Kjersti M Aagaard-Tillery, Diane F Jelinek, Differential activation of a calcium-dependent endonuclease in human B lymphocytes. Role in ionomycin-induced apoptosis. Journal of Immunology. ,vol. 155, pp. 3297- 3307 ,(1995)
B E Magun, R Kibler, D H Russell, L Matrisian, B Poulos, D F Larson, Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. Journal of Immunology. ,vol. 134, pp. 3027- 3031 ,(1985)
Michael Hallek, P. Leif Bergsagel, Kenneth C. Anderson, Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process Blood. ,vol. 91, pp. 3- 21 ,(1998) , 10.1182/BLOOD.V91.1.3
Janine A. Davis, Daniel I. H. Linzer, Autocrine stimulation of Nb2 cell proliferation by secreted, but not intracellular, prolactin. Molecular Endocrinology. ,vol. 2, pp. 740- 746 ,(1988) , 10.1210/MEND-2-8-740
Carol Reynolds, Kathleen T. Montone, Colleen M. Powell, John E. Tomaszewski, Charles V. Clevenger, Expression of prolactin and its receptor in human breast carcinoma. Endocrinology. ,vol. 138, pp. 5555- 5560 ,(1997) , 10.1210/ENDO.138.12.5605
Lina Matera, Miguel Cutufia, Massimo Geuna, Maria Contarini, Stefano Buttiglieri, Shawn Galin, Annamaria Fazzari, Cristina Cavaliere, PROLACTIN IS AN AUTOCRINE GROWTH FACTOR FOR THE JURKAT HUMAN T-LEUKEMIC CELL LINE Journal of Neuroimmunology. ,vol. 79, pp. 12- 21 ,(1997) , 10.1016/S0165-5728(97)00096-9
P. Sabharwal, R. Glaser, W. Lafuse, S. Varma, Q. Liu, S. Arkins, R. Kooijman, L. Kutz, K. W. Kelley, W. B. Malarkey, Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 7713- 7716 ,(1992) , 10.1073/PNAS.89.16.7713
Klára Gadó, Éva Rimanóczi, Ágnes Hasitz, Gábor Gigler, Béla E. Tóth, György M. Nagy, Katalin Pálóczi, Gyula Domján, Elevated Levels of Serum Prolactin in Patients with Advanced Multiple Myeloma Neuroimmunomodulation. ,vol. 9, pp. 231- 236 ,(2001) , 10.1159/000049031